Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Binding sites for [3H]-melatonin in human platelets.

M I Vacas1, M M Del Zar, M Martinuzzo

  • 1Departamento de Fisologia, Facultad de Medicina, Buenos Aires, Argentina.

Journal of Pineal Research
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Effects of Factor XIII Deficiency on Thromboelastography. Thromboelastography with Calcium and Streptokinase Addition is more Sensitive than Solubility Tests.

Mediterranean journal of hematology and infectious diseases·2016
Same author

Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?

International journal of laboratory hematology·2015
Same author

Anti-β2glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an in vivo animal model.

Journal of thrombosis and haemostasis : JTH·2011
Same author

Central gabaergic mechanisms as targets for melatonin activity in brain.

Neurochemistry international·2010
Same author

Melatonin reverses pinealectomy-induced decrease of benzodiazepine binding in rat cerebral cortex.

Neurochemistry international·2010

High-affinity melatonin binding sites were identified in human platelets. These findings suggest specific melatonin receptors exist on platelets, influencing their function.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Cell Biology

Background:

  • Previous in vitro studies have indicated various effects of melatonin on human platelets.
  • The presence and characteristics of specific melatonin binding sites on human platelets remained to be elucidated.

Purpose of the Study:

  • To investigate the existence of high-affinity binding sites for [3H]-melatonin in human platelet membrane preparations.
  • To characterize the binding kinetics and specificity of these potential melatonin receptors on platelets.

Main Methods:

  • Human platelet membrane preparations were used for radioligand binding assays.
  • A rapid filtration technique with Whatman GFB paper was employed to measure [3H]-melatonin binding.
  • Scatchard analysis was performed to determine binding parameters (Kd and Bmax).

Related Experiment Videos

  • Competitive binding assays were conducted using various indole analogs and serotonin derivatives to assess specificity.

    • Main Results:

    • Maximal [3H]-melatonin binding occurred within 3 hours at 0°C.
    • Scatchard analysis revealed a single population of binding sites with a dissociation constant (Kd) of 4.1 ± 0.5 nM and a maximal binding capacity (Bmax) of 24.2 ± 1.9 fmol/mg protein.
    • 6-chloromelatonin, 2-iodomelatonin, and melatonin demonstrated high affinity for the binding sites.
    • Serotonin also potently inhibited [3H]-melatonin binding (Ki = 20.6 nM).
    • Most tested serotonin agonists and antagonists did not significantly affect melatonin binding, suggesting receptor specificity.
    • No time-dependent differences in binding parameters were observed between 0800 and 2000.

    Conclusions:

    • The results strongly suggest the presence of high-affinity melatonin acceptors (receptors) in human platelet membranes.
    • These findings provide a molecular basis for the observed in vitro effects of melatonin on human platelets.
    • Further research is warranted to explore the physiological implications of these platelet melatonin receptors.